Preclinical characterization of novel mGlu2 receptor PAMs for the treatment of substance abuse Sep. 10, 2019
InterveXion reports interim data from phase II study of IXT-m200 for methamphetamine use disorder July 30, 2019
PledPharma reports results from POP phase I trial of calmangafodipir for paracetamol overdose July 18, 2019
RSS